Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-006836

Chief Scientific Officer acquired 1,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2022-02-01 Option exercise +1,050 87,684 D
Derivatives
Monahan Joseph Chief Scientific Officer 2022-02-01 Option exercise · Restricted Stock Units −1,050 0 D
Loading xslF345X03/doc4.xml…